Indoco Remedies informs about press release

22 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it enclosed a press today titled ‘Indoco Remedies receives USFDA approval for Lacosamide Tablets’.

The above information is a part of company’s filings submitted to BSE.


Indoco Remedies Share Price

329.00 4.05 (1.25%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.